Delivery Order SPE2DR25D6037-SPE2DR26FXL1C
- Not listed
- The Defense Logistics Agency awarded a $1,679.29 delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Proctofoam-HC 1%-1% Foam in a 10-gram quantity. This is a firm fixed-price contract with an ultimate completion date of January 14, 2026, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation. The place of performance...
- On January 6, 2026, the Defense Logistics Agency awarded a delivery order valued at $2,320.30 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities. This non-competitive delivery order, which will be completed by January 7, 2026, represents a firm fixed-price procurement of a topical pharmaceutical product. The award is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a substantial indefinite...
- The Defense Logistics Agency awarded a $1,998.61 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. This is a firm fixed-price, non-set-aside contract with a completion date of January 13, 2026, and performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC...
- The Defense Logistics Agency awarded a $11,418.86 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 16, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,535.65 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. This is a firm fixed-price contract with no set-aside designation, competitively awarded on a full and open basis. The contract was awarded on January 23, 2026, with an ultimate completion date of January 26, 2026. Performance will take place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order valued at $1,327.93 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. This is a firm fixed price, non-set-aside contract with an ultimate completion date of January 5, 2026. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award from the Defense Logistics Agency (DLA) on January 14, 2026, for Proctofoam-HC 1%-1% Foam in 10-gram units. The contract is valued at $2,484.68 with a firm fixed-price structure and no set-aside designation, indicating it was competitively awarded. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 15, 2026. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $8,187.60 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in 10-gram quantities. This non-competitive delivery order was issued on January 28, 2026, with an ultimate completion date of January 29, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The contract employs firm fixed-price pricing and represents a routine pharmaceutical procurement supporting federal medical supply needs....
- The Defense Logistics Agency awarded a delivery order valued at $2,764.08 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. This non-competitive, firm fixed-price delivery order was executed on January 27, 2026, with an ultimate completion date of January 28, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,135.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for Proctofoam-HC 1%-1% Foam in 10-gram units. This is a non-set-aside competitive award with an ultimate completion date of October 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DR25D6037Indefinite Delivery Contract
- SPE2DR25D6037-SPE2DR26FXL1CDelivery Order
This delivery order, valued at $1,983.16, was awarded on January 28, 2026, to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency for the supply of Proctofoam-HC 1%-1% Foam in a 10-gram unit. The award is non-competitive and represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The product will be delivered to Conshohocken, Pennsylvania, with a completion deadline of January 29, 2026. This contract is structured as a firm fixed-price arrangement with no set-aside designation, reflecting competitive procurement principles within the DLA's pharmaceutical supply chain. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for military healthcare systems and other federal medical institutions through this expansive IDC vehicle. The company's portfolio encompasses a comprehensive range of medications, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare programs globally. The delivery order for Proctofoam-HC, a topical foam medication, exemplifies the routine pharmaceutical procurement activities conducted through this prime vendor agreement, enabling efficient fulfillment of essential medical supply needs across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/27/26 |